EdgarLookup
SC 13D/A

AMENDMENT NO. 1 TO SCHEDULE 13D

Company
Aptose Biosciences Inc.
Filed
February 5, 2024
Accession Number
0001213900-24-009767
View Document ↗ View on SEC.gov ↗